{"id":"iocarmic-acid","rwe":[{"pmid":"930633","year":"1977","title":"Effect of methylglucamine salts of iocarmic and iothalamic acids on hemodynamics, acid-base equilibrium and coagulation.","finding":"","journal":"Acta radiologica: diagnosis","studyType":"Clinical Study"}],"tags":[{"label":"iocarmic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"V08AA08","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["iocarmic acid"],"offLabel":[],"synonyms":["iocarmic acid"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"iocarmic acid","explanation":"Imagine your body's cells have a complex communication system. Iocarmic acid is believed to interact with this system, influencing how cells talk to each other and respond to signals. This interaction may help to regulate various cellular processes, but more research is needed to fully understand how it works.","oneSentence":"Iocarmic acid is thought to work by modulating a specific biological pathway, although the exact mechanism is not well understood.","technicalDetail":"Iocarmic acid is a small molecule that binds to a specific protein or receptor, altering its activity and downstream signaling pathways. This interaction may involve changes in enzyme activity, gene expression, or other cellular processes, but the precise molecular mechanisms are not yet well characterized."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1450","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IOCARMIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:06:31.878577","biosimilars":[],"competitors":[{"drugName":"diatrizoate","drugSlug":"diatrizoate","fdaApproval":"1954-11-26","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"metrizoic acid","drugSlug":"metrizoic-acid","fdaApproval":"1973-11-17","relationship":"same-class"},{"drugName":"iodamide","drugSlug":"iodamide","fdaApproval":"1978-07-25","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"iotalamic acid","drugSlug":"iotalamic-acid","fdaApproval":"1963-09-30","relationship":"same-class"},{"drugName":"acetrizoic acid","drugSlug":"acetrizoic-acid","fdaApproval":"","relationship":"same-class"}],"genericName":"iocarmic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"diatrizoate","brandName":"diatrizoate","genericName":"diatrizoate","approvalYear":"1954","relationship":"same-class"},{"drugId":"metrizoic-acid","brandName":"metrizoic acid","genericName":"metrizoic acid","approvalYear":"1973","relationship":"same-class"},{"drugId":"iodamide","brandName":"iodamide","genericName":"iodamide","approvalYear":"1978","relationship":"same-class"},{"drugId":"iotalamic-acid","brandName":"iotalamic acid","genericName":"iotalamic acid","approvalYear":"1963","relationship":"same-class"},{"drugId":"acetrizoic-acid","brandName":"acetrizoic acid","genericName":"acetrizoic acid","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"82PB24K6TZ","CHEBI":"CHEBI:31702","INN_ID":"2679","UMLSCUI":"C0063746","ChEMBL_ID":"CHEMBL2106389","KEGG_DRUG":"D01099","DRUGBANK_ID":"DB13755","PUBCHEM_CID":"25229","MESH_SUPPLEMENTAL_RECORD_UI":"C010999"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"V08AA08","allCodes":["V08AA08"]},"biosimilarFilings":[],"recentPublications":[{"date":"1977 Sep","pmid":"930633","title":"Effect of methylglucamine salts of iocarmic and iothalamic acids on hemodynamics, acid-base equilibrium and coagulation.","journal":"Acta radiologica: diagnosis"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"IOCARMIC ACID","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iocarmic acid is a small molecule drug of the iocarmic acid class, but limited information is available on its development, approval status, and commercial availability. The original developer and current owner of iocarmic acid are unknown, and its target and approved indications have not been disclosed. As a result, there is no information on its half-life, bioavailability, or generic manufacturers. Iocarmic acid's commercial status, including whether it is patented or off-patent, is also unknown. Further research is needed to understand the pharmacology and clinical utility of this compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}